BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

743 related articles for article (PubMed ID: 26584607)

  • 21. Differences in response to antiretroviral therapy in HIV-positive patients being treated for tuberculosis in Eastern Europe, Western Europe and Latin America.
    Caro-Vega Y; Schultze A; W Efsen AM; Post FA; Panteleev A; Skrahin A; Miro JM; Girardi E; Podlekareva DN; Lundgren JD; Sierra-Madero J; Toibaro J; Andrade-Villanueva J; Tetradov S; Fehr J; Caylà J; Losso MH; Miller RF; Mocroft A; Kirk O; Crabtree-Ramírez B
    BMC Infect Dis; 2018 Apr; 18(1):191. PubMed ID: 29685113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of mortality among TB-HIV Co-infected patients being treated for tuberculosis in Northwest Ethiopia: a retrospective cohort study.
    Sileshi B; Deyessa N; Girma B; Melese M; Suarez P
    BMC Infect Dis; 2013 Jul; 13():297. PubMed ID: 23815342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between tuberculosis treatment outcomes and the mobile antiretroviral therapy programme in Zambia.
    Miyano S; Dube C; Kayama N; Ishikawa N; Nozaki I; Syakantu G
    Int J Tuberc Lung Dis; 2013 Apr; 17(4):540-5. PubMed ID: 23394080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bacteriologically confirmed tuberculosis in HIV-infected infants: disease spectrum and survival.
    Wiseman CA; Schaaf HS; Cotton MF; Gie RP; Jennings T; Whitelaw A; Roux P; Hesseling AC
    Int J Tuberc Lung Dis; 2011 Jun; 15(6):770-5. PubMed ID: 21575297
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of TB/HIV Integration on TB and HIV Indicators in Rural Ugandan Health Facilities.
    Burnett SM; Zawedde-Muyanja S; Hermans SM; Weaver MR; Colebunders R; Manabe YC
    J Acquir Immune Defic Syndr; 2018 Dec; 79(5):605-611. PubMed ID: 30383587
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of HIV infection and antiretroviral therapy with the occurrence of an unfavorable TB treatment outcome in a rural district hospital in Eastern Cape, South Africa: A retrospective cohort study.
    van de Water BJ; Fulcher I; Cilliers S; Meyer N; Wilson M; Young C; Gaunt B; le Roux K
    PLoS One; 2022; 17(4):e0266082. PubMed ID: 35381042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The potential effects of changing HIV treatment policy on tuberculosis outcomes in South Africa: results from three tuberculosis-HIV transmission models.
    Pretorius C; Menzies NA; Chindelevitch L; Cohen T; Cori A; Eaton JW; Fraser C; Gopalappa C; Hallett TB; Salomon JA; Stover J; White RG; Dodd PJ
    AIDS; 2014 Jan; 28 Suppl 1():S25-34. PubMed ID: 24468944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes of TB/HIV co-infected patients presenting with antituberculosis drug-induced liver injury.
    Naidoo S; Evans D; Jong E; Mellet K; Berhanu R
    S Afr Med J; 2015 Apr; 105(5):393-6. PubMed ID: 26242667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measuring the degree of integrated tuberculosis and HIV service delivery in Cape Town, South Africa.
    Uyei J; Coetzee D; Macinko J; Weinberg SL; Guttmacher S
    Health Policy Plan; 2014 Jan; 29(1):42-55. PubMed ID: 23274439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mortality associated with tuberculosis/HIV co-infection among patients on TB treatment in the Limpopo province, South Africa.
    Mabunda TE; Ramalivhana NJ; Dambisya YM
    Afr Health Sci; 2014 Dec; 14(4):849-54. PubMed ID: 25834493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Barriers to initiation of antiretrovirals during antituberculosis therapy in Africa.
    Pepper DJ; Marais S; Wilkinson RJ; Bhaijee F; De Azevedo V; Meintjes G
    PLoS One; 2011 May; 6(5):e19484. PubMed ID: 21589868
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic significance of the interval between the initiation of antiretroviral therapy and the initiation of anti-tuberculosis treatment in HIV/tuberculosis-coinfected patients: results from the TREAT Asia HIV Observational Database.
    Han SH; Zhou J; Lee MP; Zhao H; Chen YM; Kumarasamy N; Pujari S; Lee C; Omar SF; Ditangco R; Phanuphak N; Kiertiburanakul S; Chaiwarith R; Merati TP; Yunihastuti E; Tanuma J; Saphonn V; Sohn AH; Choi JY;
    HIV Med; 2014 Feb; 15(2):77-85. PubMed ID: 23980589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence and predictors of LTFU among adults with TB/HIV co-infection in two governmental hospitals, Mekelle, Ethiopia, 2009-2016: survival model approach.
    Gezae KE; Abebe HT; Gebretsadik LG
    BMC Infect Dis; 2019 Feb; 19(1):107. PubMed ID: 30717705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment guidelines and early loss from care for people living with HIV in Cape Town, South Africa: A retrospective cohort study.
    Katz IT; Kaplan R; Fitzmaurice G; Leone D; Bangsberg DR; Bekker LG; Orrell C
    PLoS Med; 2017 Nov; 14(11):e1002434. PubMed ID: 29136014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unsuccessful TB treatment outcomes with a focus on HIV co-infected cases: a cross-sectional retrospective record review in a high-burdened province of South Africa.
    Engelbrecht MC; Kigozi NG; Chikobvu P; Botha S; van Rensburg HCJ
    BMC Health Serv Res; 2017 Jul; 17(1):470. PubMed ID: 28693508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of complete integration of HIV and TB services on time to initiation of antiretroviral therapy: a before-after study.
    Kerschberger B; Hilderbrand K; Boulle AM; Coetzee D; Goemaere E; De Azevedo V; Van Cutsem G
    PLoS One; 2012; 7(10):e46988. PubMed ID: 23071690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TB-HIV co-infection among pregnant women in Karnataka, South India: A case series.
    Suresh S; Sharath BN; Anita S; Lalitha R; Prasad TJ; Rewari BB
    J Infect Public Health; 2016; 9(4):465-70. PubMed ID: 26711476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tuberculosis prevalence, incidence and prevention in a south african cohort of children living with HIV.
    Anyalechi GE; Bain R; Kindra G; Mogashoa M; Sogaula N; Mutiti A; Arpadi S; Rivadeneira E; Abrams EJ; Teasdale CA
    J Trop Pediatr; 2022 Oct; 68(6):. PubMed ID: 36269203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tuberculosis incidence rates during 8 years of follow-up of an antiretroviral treatment cohort in South Africa: comparison with rates in the community.
    Gupta A; Wood R; Kaplan R; Bekker LG; Lawn SD
    PLoS One; 2012; 7(3):e34156. PubMed ID: 22479548
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIV and TB co-infection in the ART era: CD4 count distributions and TB case fatality in Cape Town.
    Kaplan R; Hermans S; Caldwell J; Jennings K; Bekker LG; Wood R
    BMC Infect Dis; 2018 Jul; 18(1):356. PubMed ID: 30064368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.